文献速递血液净化与透析急性肾损伤

血红蛋白12 g/dl及以上与血液透析儿童心血管疾病发病率增加无关

Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
PubMed 文献 · Kidney Int · 2016-11-16

该回顾性队列研究纳入1569例接受血液透析的儿童患者,按基线血红蛋白分组随访1年,评估死亡率、住院和心血管事件。结果显示血红蛋白12 g/dl及以上组全因死亡率风险比0.33(95%CI 0.14-0.81)、全因住院调整相对率0.81(95%CI 0.74-0.89)显著更低;血红蛋白低于10 g/dl组心血管住院显著更高(1.31,95%CI 1.05-1.64)。结论认为血红蛋白12 g/dl及以上与心血管就诊、死亡率或住院增加无关。

要点

  • 血红蛋白12 g/dl及以上组全因死亡率风险比0.33(95%CI 0.14-0.81),显著低于其他组。
  • 血红蛋白低于10 g/dl组心血管住院相对率1.31(95%CI 1.05-1.64),显著更高。
  • 血红蛋白12 g/dl及以上与心血管就诊、死亡率或住院增加无关。

核心结论

  • 在血液透析儿童中,血红蛋白12 g/dl及以上与心血管就诊、死亡率或全因及心血管相关住院增加无关。

研究设计与样本

  • 回顾性队列研究,纳入美国医疗保险和医疗补助服务中心终末期肾病临床绩效评估项目(2000至2008年)并与美国肾脏数据系统链接的1569例18岁以下血液透析儿童患者。
  • 血红蛋白取自临床绩效评估数据,自次年1月1日起每年随访最长1年,按基线血红蛋白分组判定随访期间结局(死亡率、住院和心血管事件),模型根据人口学和临床特征校正。

主要发现

  • 血红蛋白12 g/dl及以上组年龄更大、终末期肾病年限更短、接受移植更频繁。
  • 充血性心力衰竭、心肌病和瓣膜性心脏病的住院和门诊就诊在血红蛋白低于10 g/dl组最常见,且这些诊断的频率随血红蛋白升高而下降。
  • 血红蛋白12 g/dl及以上组全因死亡率风险比0.33(95%CI 0.14-0.81),全因住院调整相对率0.81(95%CI 0.74-0.89),均显著更低。
  • 血红蛋白低于10 g/dl组心血管住院显著更高(相对率1.31,95%CI 1.05-1.64)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In adults on chronic hemodialysis, achieving a hemoglobin concentration of 12g/dl and above with erythropoiesis stimulating agents leads to increased cardiovascular events and mortality, but this may not be true in children. Therefore, we conducted a retrospective cohort study of pediatric patients (under 18) from the Centers for Medicare and Medicaid Services End Stage Renal Disease (ESRD) Clinical Performance Measures (CPM) project (2000 to 2008) merged with the United States Renal Data System. Hemoglobin was determined from the Clinical Performance Measures data, and beginning annually on January 1st of the next year, patients were followed for up to 1 year. We determined the outcomes (mortality, hospitalization, and cardiovascular events) during follow-up by hemoglobin group at baseline. Models were adjusted for demographic and clinical characteristics of 1569 children studied. The hemoglobin 12 g/dl and above group was older, had fewer years of ESRD, and was more often transplanted. Inpatient and outpatient visits for congestive heart failure, cardiomyopathy, and valvular heart disease were most common in the hemoglobin under 10g/dl group and the frequency of these diagnoses decreased with increasing hemoglobin. The hazard ratio of all-cause mortality (0.33, 95% confidence interval 0.14-0.81) and the adjusted relative rate of all-cause hospitalizations (0.81, 0.74-0.89) were significantly lower in the hemoglobin 12 g/dl and above group. Cardiovascular hospitalizations were significantly higher in the hemoglobin under 10g/dl group (1.31, 1.05-1.64). Thus, in children on hemodialysis, hemoglobin 12g/dl and above is not associated with increased cardiovascular visits, mortality, or all-cause and cardiovascular-related hospitalizations.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Rheault MN, Molony JT, Nevins T, et al. Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis. Kidney Int. 2016. PMID: 27865440. doi:10.1016/j.kint.2016.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。